Can we reduce excision margins for head and neck melanoma? A 12-year retrospective study.


Journal

The British journal of oral & maxillofacial surgery
ISSN: 1532-1940
Titre abrégé: Br J Oral Maxillofac Surg
Pays: Scotland
ID NLM: 8405235

Informations de publication

Date de publication:
02 2022
Historique:
received: 31 08 2020
accepted: 15 10 2020
pubmed: 3 11 2020
medline: 6 5 2022
entrez: 6 2 2022
Statut: ppublish

Résumé

Although wide local excision is the standard treatment for primary melanoma, the surgical margin remains controversial. Melanomas of the head and neck exhibit higher recurrence rates and worse prognosis than lesions in other body locations, and their close proximity to critical anatomical and functional structures means that wide excision margins are often not feasible. Surgeons must therefore achieve a balance of oncological safety and functional and aesthetic needs. The aim of this study was to retrospectively analyse melanoma data over a 12-year period at a large skin surgery unit to identify potential differences in outcomes in patients who had reduced wide local excision margins for primary head and neck melanoma. The study would provide further evidence for the need for large randomised prospective trials to reduce excision margins for head and neck melanoma. Local cancer network data were retrospectively analysed over a period of 12 years (2008-2019). Data included site, initial stage, multidisciplinary team (MDT) meeting recommendations for excision margins and the actual wide local excision margin taken, recurrence rate, and disease-specific and absolute survival. A total of 222/305 patients (73%) had the recommended excision margin, while in 27% margins were reduced due to anatomical or functional considerations. Recurrence rates were similar (recommended 11.7% vs narrow 13.3% excision margins) (p = 0.64). The mean follow-up time for all patients was 48.5 months. In aesthetically and functionally sensitive areas of the head and neck, wide local excision margins need to be carefully considered after MDT discussion and discussion with the patient. This study suggests the need for further multicentre trials to address the uniqueness of head and neck melanoma.

Identifiants

pubmed: 35123836
pii: S0266-4356(20)30590-8
doi: 10.1016/j.bjoms.2020.10.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-139

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Auteurs

R Pandya (R)

Worcestershire Royal Hospital, Charles Cavell Way, Worcester, WR5 1DD. Electronic address: rpandya1000@gmail.com.

M Basra (M)

Worcestershire Royal Hospital, Charles Cavell Way, Worcester, WR5 1DD. Electronic address: Merendeep.basra@nhs.net.

E Twohig (E)

Worcestershire Royal Hospital, Charles Cavell Way, Worcester, WR5 1DD. Electronic address: Eoin.twohig@nhs.net.

K McVeigh (K)

Worcestershire Royal Hospital, Charles Cavell Way, Worcester, WR5 1DD. Electronic address: Kieron.mcveigh1@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH